Oral fluoropyrimidine versus intravenous 5 ‐fluorouracil for the treatment of advanced gastric and colorectal cancer: meta‐analysis

ConclusionsOral‐fluoropyrimidines showed equivalent response and similar survival outcomes, but different toxicity profiles, as compared with intravenous 5‐fluorouracil. Thus, it would be a more convenient and adjustable alternative in treatment of advanced gastric and colorectal cancer.

Source: Journal of Gastroenterology and Hepatology - June 1, 2017 Category: Gastroenterology Authors: Linlin Zhang, Xiaoli Xing, Fanlu Meng, Yan Wang, Diansheng Zhong Tags: Original Article ‐ Gastroenterology (Clinical) Source Type: research